DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
MIV-818
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIV-818
×
Maximum Phase:
1
First Approval:
None
UNII:
Q1I6YZ0NGF
Molecule Type:
Small molecule
Molecular Formula:
C22H30BrN4O8P
Molecular Weight:
589.38
AlogP:
3.37
PSA:
153.23
HBD:
2.0
HBA:
#RotB:
12.0
Source:
ABT-102
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vanilloid receptor antagonist
ABT-102
×
Maximum Phase:
1
First Approval:
None
UNII:
J0YBN3USJN
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O
Molecular Weight:
348.45
AlogP:
4.67
PSA:
69.81
HBD:
3.0
HBA:
#RotB:
2.0
Source:
VX-853
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VX-853
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CX-5461
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CX-5461
×
Maximum Phase:
1
First Approval:
None
UNII:
3R4C5YLB9I
Molecule Type:
Small molecule
Molecular Formula:
C27H27N7O2S
Molecular Weight:
513.63
AlogP:
3.23
PSA:
95.73
HBD:
1.0
HBA:
#RotB:
4.0
Source:
L-778123
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
L-778123
×
Maximum Phase:
1
First Approval:
None
UNII:
2A2059P49U
Molecule Type:
Small molecule
Molecular Formula:
C22H20ClN5O
Molecular Weight:
405.89
AlogP:
3.31
PSA:
65.16
HBD:
0.0
HBA:
#RotB:
5.0
Source:
OSI-027
1
Small molecule
Investigational
Unknown
Unknown
Lymphedema; Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
OSI-027
×
Maximum Phase:
1
First Approval:
None
UNII:
25MKH1SZ0M
Molecule Type:
Small molecule
Molecular Formula:
C21H22N6O3
Molecular Weight:
406.45
AlogP:
3.22
PSA:
131.42
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ISOAMYL 2-CYANOACRYLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ISOAMYL 2-CYANOACRYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1070916
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora-B inhibitor
GSK-1070916
×
Maximum Phase:
1
First Approval:
None
UNII:
8VLB51V7HO
Molecule Type:
Small molecule
Molecular Formula:
C30H33N7O
Molecular Weight:
507.64
AlogP:
5.94
PSA:
82.08
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PHI-101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
PHI-101
×
Maximum Phase:
1
First Approval:
None
UNII:
U2UY9TBQ8Z
Molecule Type:
Small molecule
Molecular Formula:
C19H19FN4O2S
Molecular Weight:
386.45
AlogP:
2.26
PSA:
96.25
HBD:
4.0
HBA:
#RotB:
3.0
Source:
OTX-008
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OTX-008
×
Maximum Phase:
1
First Approval:
None
UNII:
8JI63CFH5V
Molecule Type:
Small molecule
Molecular Formula:
C52H72N8O8
Molecular Weight:
937.2
AlogP:
2.59
PSA:
166.28
HBD:
4.0
HBA:
#RotB:
24.0
Source:
MK-6592
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
MK-6592
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H26ClF2N7O2
Molecular Weight:
529.98
AlogP:
4.28
PSA:
99.27
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CEP-5214
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor inhibitor
CEP-5214
×
Maximum Phase:
1
First Approval:
None
UNII:
A3X38AF5BQ
Molecule Type:
Small molecule
Molecular Formula:
C28H28N2O3
Molecular Weight:
440.54
AlogP:
4.92
PSA:
63.49
HBD:
2.0
HBA:
#RotB:
6.0
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OMIGAPIL
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease; Amyotrophic Lateral Sclerosis
Unknown
OMIGAPIL
×
Maximum Phase:
1
First Approval:
None
UNII:
5V14HD0N4Q
Molecule Type:
Small molecule
Molecular Formula:
C19H17NO
Molecular Weight:
275.35
AlogP:
3.9
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
HYDROXYNORKETAMINE, (2R,6R)-, HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Unknown
HYDROXYNORKETAMINE, (2R,6R)-, HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
A2F3JNU7UV
Molecule Type:
Small molecule
Molecular Formula:
C12H15Cl2NO2
Molecular Weight:
276.16
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
SGI-1776
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Lymphoma, Non-Hodgkin; Prostatic Neoplasms, Castration-Resistant
Serine/threonine-protein kinase PIM inhibitor
SGI-1776
×
Maximum Phase:
1
First Approval:
None
UNII:
72AUA0603W
Molecule Type:
Small molecule
Molecular Formula:
C20H22F3N5O
Molecular Weight:
405.42
AlogP:
4.05
PSA:
54.69
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AZD-7762
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
AZD-7762
×
Maximum Phase:
1
First Approval:
None
UNII:
5D822Y3L1H
Molecule Type:
Small molecule
Molecular Formula:
C17H19FN4O2S
Molecular Weight:
362.43
AlogP:
2.53
PSA:
96.25
HBD:
4.0
HBA:
#RotB:
4.0
Source:
OXI-4503
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
Unknown
OXI-4503
×
Maximum Phase:
1
First Approval:
None
UNII:
JH6Z94GLUD
Molecule Type:
Small molecule
Molecular Formula:
C18H22O12P2
Molecular Weight:
492.31
AlogP:
2.83
PSA:
170.44
HBD:
4.0
HBA:
#RotB:
10.0
Source:
MK-1496
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
MK-1496
×
Maximum Phase:
1
First Approval:
None
UNII:
CS17H9370C
Molecule Type:
Small molecule
Molecular Formula:
C14H24N2O
Molecular Weight:
236.36
AlogP:
2.13
PSA:
58.28
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ABTL-0812
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ABTL-0812
×
Maximum Phase:
1
First Approval:
None
UNII:
0DE74TJ7EZ
Molecule Type:
Small molecule
Molecular Formula:
C18H32O3
Molecular Weight:
296.45
AlogP:
4.86
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
2MD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
2MD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-5099
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-5099
×
Maximum Phase:
1
First Approval:
None
UNII:
33BLU33GDV
Molecule Type:
Small molecule
Molecular Formula:
C21H27Cl2N5O6S
Molecular Weight:
548.45
AlogP:
2.57
PSA:
145.88
HBD:
4.0
HBA:
#RotB:
9.0
Source:
AZD-1208
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Neoplasms
Serine/threonine-protein kinase PIM inhibitor
AZD-1208
×
Maximum Phase:
1
First Approval:
None
UNII:
S98NFM1378
Molecule Type:
Small molecule
Molecular Formula:
C21H21N3O2S
Molecular Weight:
379.49
AlogP:
3.61
PSA:
75.43
HBD:
2.0
HBA:
#RotB:
3.0
Source:
GMI-1271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GMI-1271
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
HMN-214
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase PLK1 inhibitor
HMN-214
×
Maximum Phase:
1
First Approval:
None
UNII:
94E9UR0RFR
Molecule Type:
Small molecule
Molecular Formula:
C22H20N2O5S
Molecular Weight:
424.48
AlogP:
3.24
PSA:
90.62
HBD:
0.0
HBA:
#RotB:
6.0
Source:
SUPINOXIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SUPINOXIN
×
Maximum Phase:
1
First Approval:
None
UNII:
ZU8OM8V5WF
Molecule Type:
Small molecule
Molecular Formula:
C22H24FN5O4
Molecular Weight:
441.46
AlogP:
3.15
PSA:
89.05
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RO-3201195
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RO-3201195
×
Maximum Phase:
1
First Approval:
None
UNII:
TE3ESF890C
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.56
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
7.0
Source:
PF-06273340
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06273340
×
Maximum Phase:
1
First Approval:
None
UNII:
I136775ABW
Molecule Type:
Small molecule
Molecular Formula:
C23H22ClN7O3
Molecular Weight:
479.93
AlogP:
2.6
PSA:
148.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
RG-7741
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Serine/threonine-protein kinase Chk1 inhibitor
RG-7741
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
S-3304
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Unknown
S-3304
×
Maximum Phase:
1
First Approval:
None
UNII:
BK459F050X
Molecule Type:
Small molecule
Molecular Formula:
C24H20N2O4S2
Molecular Weight:
464.57
AlogP:
3.91
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
6.0
Source:
5-AMINOVALERIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
5-AMINOVALERIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C5H11NO2
Molecular Weight:
117.15
AlogP:
0.2
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NMS-1116354
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cell division cycle 7-related protein kinase inhibitor
NMS-1116354
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
61
62
63
64
65
66
67
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA